ﾕ〇 Y{ﾕZﾅdｯ 2013 µZ{Z/ﾌｿ{ e ]

ÕZÁY{ ÕZÅd¯
2013 µZ { Z/Ì¿{e]
2Õ{§
Â¿ZÌ¯ f¯{ ,1½ZËÁÌa {Y§ f¯{
ÖfÆ] |ÌÆ Ö°a ¹Â¸ ÃZ´¿Y{ ÕZÁY{ Ã|°¿Y{ ÁY{ {Zf«Y Á dËË|» ÃÁ³ .1
ÖfÆ] |ÌÆ Ö°a ¹Â¸ ÃZ´¿Y{ ÕÁY{ Á Y~£ d¿ÁZ » .2
17 Ä^e Ä] 2012 µZ { 11 Ä^e Y BMS d¯
2000 µZ Y .dY Ã{¯ Â¬// 2013 µZ {
|{ 50 {Á|u ,ZÌ¿{ e] ÉZ//ÁY{ d¯// Ã{
|¿YÃ{Y{ ZfyY {Ây Ä] Y ÁY{ Ê¿ZÆm YZ] ºÆ
2007 µZ { Á |{ 42 {Á|u 2012 µZ// {)
d^i ªu ÃÁ{ Ä¯ ÊËZÅYZ] { .(|{ 43 {Á|//u
ÕZÅd¯ d]Z« Ê¸Y ¶v» Á {Â//Ö» dËZ
ZÌ¿{ ÊËÁY{ ±] d¯ 10 ,dY ÊËÁY{ ±]
.|¿YÃ{Y{ ZfyY {Ây Ä] Y YZ] ºÆ// |{ 52
ÕZÅµZ { ZÅd¯ ¾Ì¼Å ºÆ Ä]Z» ºÆ ¾ËY
.dY 2007 Á 2012
ÉZÁY{ d¯ 50 ,2013 µZ// Y³ {
ÄËZ¬» ¦¸fz» ÃÂu 5 { ZÅd¯ ËZ// Z] e]
.|¿YÃ|
Zf¿Y Ä] ¹Y|«Y Pharm Exec Ä¸n» ,2000 µZ Y
Zv· Y ZÌ¿{ e] ÉZ//ÁY{ d¯ 50 dÆ§
d^¿ Ä] 2013 µZ// d//Æ§ .{Â¼¿ YZ] Y
{Â» { m Ä] ,ÄfY{ Ê¼¯ cYÌÌ¤e 2012 µZ//
ZÅ½M {Â d^¿ Ä¯ Z ®Ë¿ ±] ÕZÅd¯
.dY Ã{Â] fÌ] Z |¿] ÕZÅd¯ Z] ÄËZ¬» {
®Ë { Z ®Ë¿ ®Ë ½YÂÀ Ä] Teva d¯
dÆ§ ºÅ{ZË Ä^e { Á Eli Lilly d¯// Ê»|«
Y« 2013 µZ { ZÌ¿{ e] ÉZÁY{ d¯ 50
50 d//Æ§ {YÁ Z] ¾Ì·ÁY ÉY] Ranbaxy .{Y{
Êy] .dY Ã|Ë{³ ZÌ¿{ e] ÉZ//ÁY{ d¯//
ÉZÅÁY{ d^i ªu xËZe ÉZ¬¿Y iY { ZÅd¯//
ÅZ¯ ,ÄnÌf¿ { Á {Â Á |»M{ ÅZ¯ Z] ,½Z|¿]
µZj» Â Ä] .|¿| Á]Á dÆ§ ¾ËY { {Ây Ä^e
294 Êa { Êa
486
93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ ÉY
14
cÓZËY YZ] µZ Ä] µZ Ê¨À» | ,(1) Y{Â¼¿
.|Å{Ö» ½Z¿ Y Z°Ë»M Ã|vf»
d^¿ Ä] 2012 µZ { d¯ 13 ¾ËY {°¸¼
.|Å{Ö» ½Z¿ Y É|{ 10 ÅZ¯ ,{Ây ¶^« µZ
d¯ 50 d//Æ§ ÕZÅd¯ ËZ// {°¸¼
|// ÕYY{ (d¯// 13 ¾ËY Y Ì£) e] ÊËÁY{
{°¸¼ ,(1) Y{Â¼¿ { ÊËÓZ] y .|ÀZ]Ö» Ê¼¯
e] d¯ 50 Y kZy ÊËÁY{ ÕZÅd¯ ËZ//
cÓZËY { (d¯// 600 Y Ì] {Y| e Ä]) ÊËÁY{
Ä¯ Â½Z¼Å .|//Å{Ö» ½Z//¿ Y Z°Ë»M Ã|//vf»
\¸£Y Ä¯ ZÅd¯// ¾ËY | ,{{³Ö» Ã|ÅZ//»
|À//Z]Ö» |¿] Á ®Ë¿ ÉZÅÁY{ Y Ö¨Ì ÉYY{
ÄuÔ» ¶]Z« ,e] ÊËÁY{ d¯ 50 Z] ÄËZ¬» {
{Ây | Y Ê¼Æ» d¼« ZÅd¯ ¾ËY ,Äf^·Y .dY
Á |¿] ÉZÅÁY{ d^i ªu ÃÁ{ ÉZ¬¿Y ½Â//Ë|» Y
.|ÀfÅ {Ây |Ë|m ®Ë¿ ÉZÅÁY{ Á§
É| ,e] ÊËÁY{ d¯// 50 ,ZaÁY ÃÂu {
®qÂ¯ ,Y³ ¾ËY { ÄmÂe ¶]Z« Äf°¿ |ËZ//
¾Ì·ÁY ÉY] Z°Ë»M Ã|vf» cÓZËY ÊËÁY{ YZ] ½|
Y ÊZ¿ ZÆÀe Ä¿ ½| ®qÂ¯ ¾ËY .|Z] xËZe { Z]
ºÆ» |¿] ÉZÅÁY{ Y Êy] d^i ªu ÃÁ{ ÉZ¬¿Y
dY Zyprexa Á Lipitor , Seroquel , Plavix |À¿Z»
ÕZÅz] ÕZÅÉÌ³dz Y ÊZ¿ |¿YÂeÖ» Ä°¸]
Y« Âa dve Á |ÌËZe ÉY] dyY{aZ] Á ÊeZ¿
Ê¨À» | Ã|¼ d¼« .|Z] |Ë|m ÉZÅÁY{ ½{Y{
Ä¯ dY ÖËZÅd¯ |»M{ ÅZ¯ Y ÊZ¿ ,Ê¸¯
{Ây ÉZÅÁY{ Y Êy] dÀfa ÃÁ{ ÉZ¬¿Y ¶Ì·{ Ä]
ÄmYÂ» Ó{ {ZÌ¸Ì» 5 Y //Ì] É|»M{ ÅZ¯ Z//]
ÃÁ{ { d¯ 13 Z°Ë»M Ã|vf» cÓZËY { .|¿YÃ{Â]
ÄmYÂ» |»M{ ÅZ¯ ¾ËY Z] 2012 Ze 2008 Ê//¿Z»
:Y |ÀeZ^ d¯ 13 ¾ËY .|¿YÃ{Â]
Eisai , Boehringer-Ingelheim , Forest
li Lilly , Sanofi , Novartis , AZ , BMS , J&J
. Roche Á , Merck , Takeda , GSK , Pfizar
ÊËÁY{ d¯ Â¿ ZY ] Z°Ë»M Ã|vf» cÓZËY ÊËÁY{ YZ] {°¸¼ / 1 Y{Â¼¿
15
ÉY 93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ
294 Êa { Êa
487
2013 µZ { ZÌ¿{ e] ÕZÁY{ ÕZÅd¯
|¿] ÉZÅÁY{ Y Êy] d^i ª//u ÃÁ{ ÉZ¬¿Y Y
µZ { É|{ 6 | ÅZ¯ Á Ã{Â] ÄmYÂ» {Ây
.|¿{¯ Ä]ne Y 2012
ÊËÁY{ YZ] ¾Ì»Â ½YÂÀ Ä] ¾aY ÊËÁY{ YZ]
Ä] YZ//] |// ÅZ¯ |ÅZ// Ì¿ ,½ZÆm ±//]
Y{Â¼¿ { Ä¯ Â½Z¼Å .{Â] 2011 µZ// d^//¿
ÉZ^mY //ÅZ¯ d//ZÌ ,{Â//Ö» ÄuÔ» (3)
¶°// Á] hZ] ,¾aY d·Á{ //Âe ÁY{ d¼Ì«
Y ¶^« µZ// Ä] d^//¿ ÅZ¯ Z] Á É|{ ¨
ÊËÁY{ ÕZÅd¯ {°¸¼ ÅZ¯ .|ÀÅ{Ö» ½Z¿
ÕZÅd//ZÌ Y Ê//Z¿ f//Ì] ,ZaÁY ÄË{ZveY {
{ ZaÁY Ä//Ë{ZveY Ê¸Y Â//¯ 5 Ê¸¯ Ê//fZË
cÓZËY ¥Ôy] .dY Ã{Â] É{Zf«Y {Â¯ Z] Ä¸]Z¬»
Ä¯ É|¿] ÉZÅÁY{ ZÅÂ¯ ¾ËY { ,Z°Ë»M Ã|vf»
Ä]Z» ½ZÀqºÅ ,Ã| Ê¬À» ZÅ½M d^i ªu ÃÁ{
dyY{aZ] ¹Z¿ //Âa dve ®Ë¿ ÉZ//ÅÁY{
ÊËÁY{ d¯ Â¿ ZY ] ZaÁY ÄË{ZveY ÊËÁY{ YZ] {°¸¼ / 2 Y{Â¼¿
Pfizer d¯ 5 .d//Y Ã|// Y{Â¼¿ { Ê³Y´Ë
Á Merck , Sanofi , Dainippon Sumitomo
ÊZ¿ Ó{ {ZÌ¸Ì» 5 Y Ì] |»M{ ÅZ¯ Z] Eisai
|¿] ÉZÅÁY{ Y Êy] d^i ª//u ÃÁ{ ÉZ¬¿Y Y
{°¸¼ ,d¯// 5 ¾ËY ½{¯ kZy Z] Á Ã{Â] {Ây
e] ÊËÁY{ d¯ 50 dÆ§ ÕZÅd¯ ËZ
{{³Ö» Ã|ÅZ//» Ä¯ Â½Z¼Å .d//Y Ã{Â] fÆ]
Ê¨À» |Àq //Å ¾aY { d¯// 5 ¾ËY {//°¸¼
.|Z]Ö» fÆ] Ê¿ZÆm Âf» d^//¿ Ä] Ê·Á Ã{Â]
ZÅd¯// ¶Ì·{ ¾Ì¼Å Ä] Á |¿Ì³Ö» Y« d//·Á{
{Ây |¿] ÉZÅÁY{ d//¼Ì« ÅZ¯ Ä] Ê¸ËZ¼e //Ì¿
{ÂmÁ ¾ËY Z] .|ÀfÌ¿ d^i ªu ÃÁ{ ÉZ¬¿Y Y | ]
ÉZÅÁY{ Á//§ ÅZ¯ ,ÊfZË ÕZÅd//ZÌ
.dY Äf//Y{ µZ^¿{ Ä] Ì¿ Y ZaÁY ÄË{ZveY { |¿]
ÄË{ZveY { ÉZÁY{ d À {°¸¼ ,Â¼n» {
d¯// 7 ,Ã{Â] fÆ] Z°Ë»M Ã|vf» cÓZËY Y ZaÁY
Á Novartis , Pfizer Sanofi , Merck GSK , AZ
ÊZ¿ Ó{ {ZÌ¸Ì» 5 Y Ì] |»M{ d§Y Z] Takeda
294 Êa { Êa
488
93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ ÉY
16
Õ{§ Â¿ZÌ¯ f¯{ ,½ZËÁÌa {Y§ f¯{
ÊËÁY{ d¯ Â¿ ZY ] ¾aY ÊËÁY{ YZ] {°¸¼ / 3 Y{Â¼¿
5 { .|¿YÃ{¯ Ä]ne {Ây ¶^« µZ// d^//¿ Ä] Y
Á{ Å ,®Ë¿ Á |//¿] ÉZÅÁY{ YZ//] ÌyY µZ//
Â Ä] .|¿YÃ{Â] Y{Ây] |// Y ZÅÂ¯ ¾ËY {
{ ®Ë¿ Á |¿] ÉZÅÁY{ Á§ |// //Âf»
10 {Á|u ,//ÌyY µZ// 5 µÂ { ZÅÂ//¯ ¾//ËY
ÊËÁY{ ÕZÅd¯ {°¸¼ | .dY Ã{Â] |{
{ {°¸¼ ÅZ¯ Äf¿YÂf¿ ZÅÂ//¯ ¾ËY { e]
½Y^m Y ZaÁY ÄË{ZveY Á Ã|//vf» cÓZËY ÉZÅYZ]
ÊËÁY{ d¯// 50 {°¸¼ ,(4) Y{Â¼¿ { .|ËZ¼¿
dÆ§ Y kZy ÕZÅd¯ ËZ {°¸¼ Z] e]
ËZ Y ÂÀ» .dY Ã| ÄËZ¬» ,e] ÕZÅd¯
ÊeZaÂ¼Å ,OTC ÉZÅÁY{ ,Y{Â¼¿ ¾ËY { cÓÂv»
Ã|ÅZ» Ä¯ Â½Z¼Å .|Z]Ö» ÊÀÌq ÊfÀ \ Á
Y kZy ÕZÅd¯ ËZ// {°¸¼ | ,{ÂÖ»
ËZ z] { ,e] ÊËÁY{ d¯// 50 dÆ§
ZÌ] ,e] ÕZÅd¯ Z] Ä//ËZ¬» { ,cÓÂv»
.dY Ã{Â] fÆ]
|Ë|m ÊËÁY{ ÕZÅµÂ°·Â» {Y| e ,(5) Y{Â//¼¿ {
17
ÉY 93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ
294 Êa { Êa
489
ZÅd¯// e \//ZÀ» {°¸¼ ,ÂÂ» ¾ËY d¸
Á ¾aY YZ] Ä] |Ë|m ÉZ//ÅÁY{ {ÁÁ Á Ê//§ » {
ZÅ½M ÉZÅÁY{ d¼Ì« f¼¯ ÉZ^mY ÅZ¯ ¾ÌÀqºÅ
.|Z]Ö» (NHS) Â¯ ¾ËY d»Ô ¹Z¿ ÉÂ// Y
Y |{ 6 Ze 5 Ä¿ÓZ ,2000 µZ// Ze ¾aY d·Á{
{ 2010 µZ Y Z»Y {¯Ö» º¯ ZÅÁY{ ¶¯ d¼Ì«
¾ËY ,YZ] { Ê¸Y |¿] ÉZÅÁY{ Y dËZ¼u d//Æm
{ Á | f¼¯ ZÅÁY{ ¶Ì^« ¾ËY ÉY] d¼Ì« ÅZ¯
ªu Y ÉZÅÁY{ ÉY] ÉfÌ] d¼Ì« ÅZ¯ ¶]Z¬»
dZÌ ¾ËY .|Ë{³ µZ¼Y ®Ë¿ Á Ã| kZy d^i
½ZÆm ÊËÁY{ ±] ÕZÅd¯ Êfu Ä¯ | hZ]
ZÅÂ¯ ËZ// Y e{Á Y {Ây |Ë|m |¿] ÉZÅÁY{
.|ÀËZ¼¿ YZ] Ä¿YÁ Á Ê§ » ¾aY {
ÉZÅÂ¯ YZ] ,ZÌ¿{ ÊËÁY{ s» YZ] ¾Ì»ZÆq
{ {ÂmÂ» ÕZÅd¯// Ä¼Å .|//Z]Ö» Â//ÆÂ¿
ÉZÅÂ¯ { ,e] ÊËÁY{ d¯// 50 d//Æ§
ÖËZÅd¯ Y Äf{ ½M Ê·Á |¿Y|¿ Âu ÂÆÂ¿
É]Y] Á{ É| ,|ÀfÅ µZ § ZÅÂ¯ ¾ËY { Ä¯
2013 µZ { ZÌ¿{ e] ÕZÁY{ ÕZÅd¯
ÂÆÂ¿ ÉZÅÂ¯ { ÊËÁY{ ÕZÅd¯ ËZ Á e] ÊËÁY{ d¯ 50 {°¸¼ ÄËZ¬» / 4 Y{Â¼¿
a ÊËÁY{ |Ë|m µÂ°·Â» ¾ËfÌ] ,2012 µZ//
ÂÂ» ¾ËY .dY Ã|Ì |ÌËZe Ä] 1999 µZ// Y
¶^« ÕZÅµZ d^¿ Ä] 2012 µZ { Ã|// |ÌËZe
{ {ÂÖ» Ã|ÅZ» Ä¯ Â½Z¼Å .dY Ã| Ã{ÁM
{ Ã| |ÌËZe ÊËÁY{ |Ë|m ÕZÅµÂ°·Â» {Y| e ÄËZ¬» / 5 Y{Â¼¿
¦¸fz» ÕZÅµZ { Z°Ë»M Ã|vf» cÓZËY
294 Êa { Êa
490
93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ ÉY
18
Õ{§ Â¿ZÌ¯ f¯{ ,½ZËÁÌa {Y§ f¯{
|¿YÂf] Ä¯ ÊËÁY{ |Ë|m ÕZÅµÂ°·Â» Ê§ » Á ¦¯
d]Z« lËY ÊËÁY{ ÕZÅ½Z»{ Z] z» Â Ä]
Y Éf¼¯ ÄÀËÅ ,fÌ] Ê//z]iY ¾¼ Á Ã{¯
Á{ dÌ¼ÅY Y Á Ã| ¶°//» ZÌ//] ,|À¯ \¸ Ì¿
.|Z]Ö» Y{Ây] Ê¿Y|Àq
e] ÊËÁY{ d¯ 50 Ä] Â]» µÁ|m Ë {
¹Zn¿Y ÄÀËÅ Á Á§ ½YÌ» ÃY¼Å Ä] 2013 µZ {
{Ây Ä Âe Á ªÌ¬ve z] { ZÅd¯ ¾ËY Äf§³
Ã|ÅZ» Ä¯ Â½Z¼Å .d//Y Ã|// Ã{ÁM (R&D)
{Á|u ,dÆ§ ¾ËY e] ÊËÁY{ d¯ 50 {ÂÖ»
¾ËY .|¿YÃ{Y{ ZfyY {Ây Ä] Y Ó{ {ZÌ¸Ì» 595
ÊÀ Ë ,Y {Ây |»M{ Y |{ 18 {Á|u ZÅd¯//
ÕZÅdÌ·Z § ¥ ,Ó{ {ZÌ¸Ì» 107 ] ¢·Z] É{|
.|¿YÃ{Â¼¿ Ä Âe Á ªÌ¬ve
¹Z£{Y Á ±] ÕZÅd¯// {°¸¼ ÉÁ |¿YÂeÖ»
YZ] { Ây Ä] ÊeM ÕZÅµZ { ÊËÁY{ Ã|
ÊËY// Ä] ÌiZe ZaÁY ÄË{ZveY Á Z°//Ë»M Ê//ËÁY{
.|Z] ÄfY{
¾f§ZË µZ//^¿{ Ä] ÃYÂ//¼Å ±//] ÕZÅd¯//
|»M{ ÅZ¯ Y Ê//Z¿ Ôy ½{¯a ÉY] ÖËZÅÃY
|¿] ÉZÅÁY{ d^i ªu ÃÁ{ ÉZ¬¿Y ¶Ì·{ Ä] {Ây
¿ |» Ä¯ ÖËZÅÃY Y Ê°Ë .|À//Z]Ö» {Ây Ê¸Y
ÊËÁY{ cÓÂv» ¾f§ZË ,|Z]Ö» ZÅd¯// ¾ËY
Ã| ÄfyZÀ ÕZÅÉZ¼Ì] { Ã{Z¨fY {Â» YÁ |u
zf» ½Z°a |¿YÂf] Ä¯ÉÂ Ä] ,dY Ê¸ §
Éf//] z] Á ZÅ½Zf//Z¼Ì] { Ây Ä] ,Y
¥Â » {Ây Ä//] Y ZÅ½M ËÂne Á Ã{Â//¼¿ [Zn»
Ä¯¾ËY Ä] ÄmÂe Z] Ây Ä] ,ÂÂ» ¾ËY .|//ËZ¼¿
2013 µZ { e] ÊËÁY{ ÕZÅd¯ 50 É|À]Ä^e / 1 µÁ|m
2013
Rank
1
2
3
4
5
6
7
8
9
10
19
Company HQ
[website]
Pfizer
New York [pfzer.com]
Novartis
Basel, Switzerland [novartis.com]
Merck
Whitehouse Station, NJ [merck.com]
Sanofi
Paris, France [sanof.com]
Roche
Basel, Switzerland [roche.com]
GlaxoSmithKline
Brentford, England [gsk.com]
AstraZeneca
London, England [astrazeneca.com]
Johnson & Johnson
New Brunswick, New Jersey [jnj.com]
Abbott
Abbott Park, Illinois [abbott.com]
Eli Lilly
Indianapolis, Indiana [lilly.com]
ÉY 93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ
294 Êa { Êa
491
2012 Rx Sales
(USD billions)
2012 R&D spend
(USD millions)
$47.404
$7,046
$45.418
$8,831
$41.143
$7,911
$38.370
$6,117.8
$37.542
$8,032.2
$33.107
$5,255.7
$27.064
$4,452
$23.491
$5,362
$23.119
$2,900
$18.509
$5,074.5
2013 µZ { ZÌ¿{ e] ÕZÁY{ ÕZÅd¯
( Ä»Y{Y ) 2013 µZ { e] ÊËÁY{ ÕZÅd¯ 50 É|À]Ä^e / 1 µÁ|m
2013
Rank
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
Company HQ
[website]
Teva
Petach Tikva, Israel [tevapharm.com]
Amgen
Thousand Oaks, California [amgen.com]
Takeda
Osaka, Japan [takeda.com]
Bayer
Leverkusen, Germany [bayer.com]
Boehringer Ingelheim
Ingelheim, Germany [boehringer-ingelheim.
com]
Novo Nordisk
Bagsvaerd, Denmark [novonordisk.com]
Bristol-Myers Squibb
New York, New York [bms.com]
Daiichi Sankyo
Tokyo, Japan [daiichisankyo.com]
Astellas Pharma
Tokyo, Japan [astellas.com]
Gilead Sciences
Foster City, California [gilead.com]
Baxter International
Deerfeld, Illinois [baxter.com]
Otsuka Holdings
Tokyo, Japan [otsuka.com]
Merck KGaA
Darmstadt, Germany [merckgroup.com]
Mylan
Canonsburg, Pennsylvania [mylan.com]
Eisai
Tokyo, Japan [eisai.com]
Celgene
Summit, New Jersey [celgene.com]
CSL
Melbourne, Australia [csl.com.au]
Les Laboratories Servier
Neuilly-sur-Seine, France [servier.com]
Allergan
Irvine, California [allergan.com]
Actavis
Zug, Switzerland [actavis.com]
Mitsubishi Tanabe Pharma
Osaka, Japan [mt-pharma.co.jp]
Shire
Dublin, Ireland [shire.com]
2012 Rx Sales
(USD billions)
2012 R&D spend
(USD millions)
$17.681
$1,283
$16.639
$3,318
$15.173
$3,720.5
$14.734
$2,522.7
$13.686
$3,012
$13.478
$1,882.3
$13.155
$3,715
$11.019
$2,287.2
$10.835
$2,224.3
$9.398
$1,682.7
$8.857
$1,015
$8.385
$1,869.5
$7.709
$1,551.6
$6.697
$388.9
$6.181
$1,423.5
$5.369
$1,412.1
$5.345
$423.5
$4.931
$1,232.7
$4.756
$926.8
$4.716
$401.8
$4.547
$853.2
$4.407
$848.8
294 Êa { Êa
492
93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ ÉY
20
Õ{§ Â¿ZÌ¯ f¯{ ,½ZËÁÌa {Y§ f¯{
( Ä»Y{Y ) 2013 µZ { e] ÊËÁY{ ÕZÅd¯ 50 É|À]Ä^e / 1 µÁ|m
2013
Rank
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
Company HQ
[website]
Chugai Pharmaceutical
Tokyo, Japan [chugai-pharm.co.jp]
Biogen Idec
Weston, Massachusetts [biogenidec.com]
Dainippon Sumitomo Pharma
Osaka, Japan [ds-pharma.com]
UCB
Brussels, Belgium [ucb.com]
Fresenius
Bad Homburg, Germany [fresenius-kabi.com]
Menarini
Florence, Italy [menarini.com]
Grifols
Barcelona, Spain [grifols.com]
Valeant Pharmaceuticals International
Mississauga, Ontario [valeant.com]
Forest Laboratories
New York, New York [frx.com]
Purdue Pharma
Stamford, Connecticut [purduepharma.com]
Kyowa Hakko Kirin
Tokyo, Japan [kyowa-kirin-pharma.com]
Hospira
Lake Forest, Illinois [hospira.com]
Lundbeck
Copenhagen, Denmark [lundbeck.com]
Endo Health Pharmaceuticals
Malvern, Pennsylvania [endo.com]
Warner Chilcott
Dublin, Ireland [wcrx.com]
STADA Arzneimittel
Bad Vilbel, Germany [stada.de]
Shionogi
Osaka, Japan [shionogi.com]
Ranbaxy Laboratories
Haryana, India [ranbaxy.com]
Total
2012 Rx Sales
(USD billions)
2012 R&D spend
(USD millions)
$4.359
$761.1
$3.783
$1,326.3
$3.625
$723.2
$3.566
$1,064.6
$3.445
$270
$3.045
$220.7
$3.000
$137.7
$2.957
$79.1
$2.903
$891.4
$2.678
$434.4
$2.575
$551.2
$2.570
$303.6
$2.349
$503.5
$2.329
$137.7
$2.306
$103
$2.241
$69.0
$2.162
$647.5
$2.049
$112.9
$594.804
$107,314.3
]ZÀ»
21
1. Noor W. Kleinrock M. 2013 Pharm Exec Top
50. Pharmaceutical Executive 2013; 33(5): 19-29
3. http://www.currentpartnering.com/insight/
company-tracker/top-50-pharma
2. http://www.pmlive.com/toppharmalist/Top
50pharmaceutical products by golbal sales
4. http://healthcare.globaldata.com
ÉY 93 Ìe . 6 ÃZ¼ . ºnÀaÁdÌ]µZ
294 Êa { Êa
493
5. http://www.evaluategroup.com

Download Report